Clinical trial
Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance
NCT00139984 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00139984 |
|---|---|
| Title | Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance |
| Official title | Impact of Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance in Medical Outpatients: The Hyper-ABC Study |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Device |
| Interventions | 24 hour blood pressure measurement |
| Enrollment | 170 |
| Start date | Oct 1, 2003 |
| Completion | May 1, 2007 |
| First posted | Aug 31, 2005 |
| Last update posted | Feb 2, 2017 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: